Physician

Alexander Rapisarda

According to 2025 Medicare claims, Alexander Rapisarda (NPI: 1811994692) practices gastroenterology in the Lakewood-New Brunswick, NJ market, with the plurality of this provider's patient population coming from Middlesex, NJ. This provider's primary affiliated billing organization is ALLIED DIGESTIVE HEALTH, LLC (NPI: 1265831259; TIN: 463915494) and primary practice location at 08816-5849. Rapisarda is affiliated with the Vytalize Health 9 ACO LLC (ACO ID: D0313), participating under the REACH model.

Rapisarda's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 534 traditional Medicare patients, billed 1,611 HCPCS/CPT codes, and received $131,970 in Medicare payments. The top billing code was 45380 (Biopsy of large bowel using a flexible endoscope). Part D data shows 1,317 prescription claims across 425 beneficiaries totaling $382,347 in drug costs, led by Linzess (Linaclotide). Open Payments data shows 78 records totaling $1,210. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs started with an early spike, then settled into a lower baseline, moving from $817,602 to $382,347. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	480	1,216	$141,289
2016	528	1,325	$139,543
2017	512	1,343	$141,829
2018	516	1,208	$134,164
2019	516	1,392	$146,958
2020	437	1,172	$105,277
2021	448	1,145	$122,483
2022	481	1,174	$131,783
2023	439	1,030	$107,594
2024	534	1,611	$131,970

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	306	1,209	$817,602
2016	316	1,251	$513,997
2017	321	1,205	$212,822
2018	346	1,073	$293,388
2019	375	1,086	$181,457
2020	301	994	$209,289
2021	329	981	$201,399
2022	321	1,054	$396,130
2023	398	1,185	$411,616
2024	425	1,317	$382,347

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
45380	Biopsy of large bowel using a flexible endoscope	112	112	$142
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	70	70	$119
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	333	556	$98
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	79	83	$73
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	308	429	$14

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Linzess	Linaclotide	61	3,690	$62,603
Xifaxan	Rifaximin	12	344	$39,554
Mesalamine	Mesalamine	24	1,856	$14,785
Sutab	Sod Sulf/Pot Chloride/Mag Sulf	80	114	$12,749
Famotidine	Famotidine	591	51,720	$11,409

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	78	$1,210	ABBVIE INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Alexander Rapisarda?

Tedicare shows public-source Medicare data for Alexander Rapisarda (NPI 1811994692), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Alexander Rapisarda have ACO affiliation data?

Alexander Rapisarda is shown with ACO affiliation data for Vytalize Health 9 ACO LLC (REACH, ACO ID D0313).

What billing organization is linked to Alexander Rapisarda?

Alexander Rapisarda is linked to ALLIED DIGESTIVE HEALTH, LLC (billing NPI 1265831259) in the available physician profile data.

Does Alexander Rapisarda have Open Payments data?

Alexander Rapisarda has 78 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.